Global Blood Therapeutics rakes in $48 mln Series B
South San Francisco, Calif.-based Global Blood Therapeutics, a biopharmaceutical firm that focuses on treating severe blood disorders, has raised $48 million in Series B funding. The investors included Wellington Management Company, RA Capital, Deerfield Management, Sabby Capital and Perceptive Life Sciences.
6 January 2015•3 mins read
